Abstract
Methylmalonic acidemia is a frequent, otosomal resessive inherited disorder of organic acid metabolism. In this disorder, the accumulation and excretion of methylmalonic acid and its metabolites are increased. The patients are treated with a diet, low in isoleucin, valin, methionin and treonin and with supplementation of biotin, kobalamine and L-carnitene. The survival and neurologic outcome in methylmalonic acidemia is determined by the biochemical response to pharmacological doses of cobalamine and the age of onset of symptoms. We report a case with methylmalonic acidemia presented with poor sucking, vomitting, ketoacidosis, profound hypotonia beginning from the first day of life with the data from the literature.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
